scispace - formally typeset
K

Konrad Hochedlinger

Researcher at Harvard University

Publications -  172
Citations -  38007

Konrad Hochedlinger is an academic researcher from Harvard University. The author has contributed to research in topics: Reprogramming & Induced pluripotent stem cell. The author has an hindex of 77, co-authored 166 publications receiving 35354 citations. Previous affiliations of Konrad Hochedlinger include University of Vienna & Free University of Berlin.

Papers
More filters
Journal ArticleDOI

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

TL;DR: The results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.
Journal ArticleDOI

Disease-Specific Induced Pluripotent Stem Cells

TL;DR: The generation of induced pluripotent stem cells from patients with a variety of genetic diseases with either Mendelian or complex inheritance are described, offering an unprecedented opportunity to recapitulate both normal and pathologic human tissue formation in vitro, thereby enabling disease investigation and drug development.
Journal ArticleDOI

Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution

TL;DR: Genome-wide analysis of two key histone modifications indicated that iPS cells are highly similar to ES cells, and data show that transcription factor-induced reprogramming leads to the global reversion of the somatic epigenome into an ES-like state.
Journal ArticleDOI

Induced pluripotent stem cells generated without viral integration

TL;DR: This work generated mouse induced pluripotent stem cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc, providing strong evidence that insertional mutagenesis is not required for in vitro reprogramming.
Journal ArticleDOI

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

TL;DR: It is shown that iPSCs obtained from mouse fibroblasts, hematopoietic and myogenic cells exhibit distinct transcriptional and epigenetic patterns, and it is demonstrated that cellular origin influences the in vitro differentiation potentials of iPSC into embryoid bodies and different hematopsic cell types.